Page last updated: 2024-09-03

glycerophosphoinositol 4,5-bisphosphate and Cardiac Conduction Defect

glycerophosphoinositol 4,5-bisphosphate has been researched along with Cardiac Conduction Defect in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abderemane-Ali, F; Amarouch, MY; Baró, I; Brasseur, R; Coyan, FC; Loussouarn, G; Marionneau, C; Mérot, J; Mordel, J; Nicolas, CS; Piron, J; Steenman, M; Thomas, A1

Other Studies

1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Cardiac Conduction Defect

ArticleYear
A long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cell Line; Chlorocebus aethiops; Cholesterol; COS Cells; Heart Conduction System; KCNQ1 Potassium Channel; Long QT Syndrome; Magnesium; Mutation; Phosphatidylinositol 4,5-Diphosphate

2014